No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4880055 |
chr9:139487092-139487093 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs183920576 |
chr9:139487119-139487120 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs573311891 |
chr9:139487138-139487139 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs112028691 |
chr9:139487148-139487149 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs188345348 |
chr9:139487156-139487157 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs202002775 |
chr9:139487168-139487169 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs559130940 |
chr9:139487183-139487184 |
Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs560004109 |
chr9:139487237-139487238 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs575964722 |
chr9:139487264-139487265 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs7026449 |
chr9:139487273-139487274 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs561609956 |
chr9:139487276-139487277 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs111651484 |
chr9:139487296-139487297 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs75496404 |
chr9:139487297-139487298 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs12682786 |
chr9:139487347-139487348 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs140266428 |
chr9:139487356-139487357 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs7030467 |
chr9:139487366-139487367 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs551257806 |
chr9:139487417-139487418 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs377121315 |
chr9:139487435-139487436 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs142705874 |
chr9:139487455-139487456 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs568878084 |
chr9:139487534-139487535 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs530674614 |
chr9:139487540-139487541 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs181832343 |
chr9:139487578-139487579 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs7020793 |
chr9:139487602-139487603 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs114501552 |
chr9:139487642-139487643 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs115585317 |
chr9:139487670-139487671 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs374088934 |
chr9:139487687-139487688 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs373676020 |
chr9:139487736-139487737 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs531401169 |
chr9:139487737-139487738 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs7030963 |
chr9:139487739-139487740 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs184921354 |
chr9:139487744-139487745 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs112785742 |
chr9:139487768-139487769 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs544867128 |
chr9:139487771-139487772 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs555279871 |
chr9:139487809-139487810 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs147532175 |
chr9:139487826-139487827 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs542223327 |
chr9:139487839-139487840 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs559321203 |
chr9:139487865-139487866 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs139424986 |
chr9:139487880-139487881 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs539220773 |
chr9:139487881-139487882 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs12337939 |
chr9:139487895-139487896 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs111640503 |
chr9:139487914-139487915 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs530614509 |
chr9:139487919-139487920 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs550386736 |
chr9:139487929-139487930 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs560831056 |
chr9:139487945-139487946 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs372319645 |
chr9:139487962-139487963 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs529962264 |
chr9:139487964-139487965 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs375356012 |
chr9:139487965-139487966 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs150035155 |
chr9:139487985-139487986 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs566870149 |
chr9:139487988-139487989 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs538699390 |
chr9:139487991-139487992 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs551205779 |
chr9:139487994-139487995 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|